AKT1 and neoplasm: IGF-1R binding with either IGF-1 or IGF-2 will undergo receptor autophosphorylation and cross-linking, and then the signals activate both PI3K/Akt/mTOR and Ras/Raf/MEK/ERK pathways to enhance tumor progression [97].